Showing results (1881-1890 of 5,552) with videos related to
Sort By:
Pageof 556
Journal of Cancer|May 29, 2018
The impact of microsatellite instability status and sidedness of the primary tumor on the effect of bevacizumab-containing chemotherapy in patients with metastatic colorectal cancerSeung Tae Kim, Hee Kyung Kim, Jeeyun Lee, et al.Journal of Cancer|May 29, 2018
Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in TaiwanShu-Yung Lin, Ching-Yao Yang, Bin-Chi Liao, et al.Journal of Cancer|May 29, 2018
Feasibility of continuing crizotinib therapy after RECIST-PD in advanced non-small cell lung cancer patients with ALK/ROS-1 mutationsJun Liu, Shaohua Cui, Feng Pan, et al.Journal of Cancer|April 21, 2018
Prognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinomaByung Su Kwon, Dae Hoon Jeong, Jung Mi Byun, et al.Journal of Cancer|April 21, 2018
Up-regulation Of EIF3e Is Associated with The Progression of Esophageal Squamous Cell Carcinoma and Poor Prognosis in PatientsFengkai Xu, Jie Gu, Lin Wang, et al.Journal of Cancer|April 21, 2018
Diagnostic accuracy of inflammatory markers for distinguishing malignant and benign ovarian massesWan Kyu Eo, Ki Hyung Kim, Eun Joo Park, et al.Journal of Cancer|April 21, 2018
A Network Meta-analysis Comparing the Efficacy and Safety of Anti-PD-1 with Anti-PD-L1 in Non-small Cell Lung CancerWei You, Mei Liu, Ji-Dong Miao, et al.Journal of Cancer|April 21, 2018
Prognostic Value of Bone Marrow FDG Uptake Pattern of PET/CT in Newly Diagnosed Diffuse Large B-cell LymphomaYumei Chen, Mingge Zhou, Jianjun Liu, et al.Journal of Cancer|May 16, 2018
LMO1 super-enhancer polymorphism rs2168101 G>T correlates with decreased neuroblastoma risk in Chinese childrenJing He, Xiaohong Zhang, Jiao Zhang, et al.Journal of Cancer|May 16, 2018
Effectiveness of Cetuximab in Combination with Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A 1:2 Propensity Score-matched AnalysisLi-Rong Wu, Huan-Feng Zhu, Jianhua Xu, et al.Pageof 556